Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

A new single-pill treatment for HIV has shown promising results. This is particularly useful for people who have had HIV for decades.

New evidence from global HIV research suggests that the first widespread cure for HIV may be possible in children who receive antiretroviral therapy (ART) early in life. Pediatrician and immunologist ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

A public health emergency is about to emerge because of federal ADAP (AIDS Drug Assistance Program) funding cuts. Long since ...

Women living with HIV/AIDS can now have safe and healthy pregnancies with early diagnosis, proper treatment, and consistent ...